Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 4,210.00
-55.00 (-1.29%)
Last updated: Nov 3, 2025, 9:50 AM KST
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 87.05 billion as of November 5, 2025. Its market cap has decreased by -21.27% in one year.
Market Cap
87.05B
Enterprise Value
104.00B
Revenue
167.81B
Ranking
n/a
PE Ratio
13.66
Stock Price
4,210.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 87.05B, an increase of 193.68%. That is a compound annual growth rate of 5.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 87.05B | -15.51% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | 176.87B | 118.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.52T |
| Celltrion | 38.68T |
| ALTEOGEN | 26.13T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.62T |